期刊文献+

多发性骨髓瘤患者血清IL-6与β2-MG水平的变化及临床意义 被引量:6

Changes of serum Interleukin-6、β2-MG Levels in Patients with Multiple Myeloma and Its Clinical Significance
下载PDF
导出
摘要 目的:探讨多发性骨髓瘤患者血清IL-6与β2-MG的变化及临床意义。方法:以本院2013年6月~2015年6月收治的60例多发性骨髓瘤患者为研究对象,以本院同期40例健康志愿者为对照组,用RIA法检测各组血清中IL-6与β2-MG表达水平,并随访观察。结果:MM组患者血清IL-6、β2-MG水平均显著高于对照组,差异均具有统计学意义(P〈0.05)。ISSⅢ期患者IL-6、β2-MG水平均高于ISSⅠ期和ISSⅡ期患者(P〈0.05)。MM患者初治组与复发难治组血清中IL-6、β2-MG的表达水平均明显高于对照组,差异有统计学意义(P〈0.05)。与初治组相比,MM患者治疗有效组IL-6、β2-MG表达水平显著降低,差异有统计学意义(P〈0.05)。MM患者复发难治组血清中IL-6、β2-MG的表达水平均明显高于初治组,差异有统计学意义(P〈0.05)。结论 :IL-6、β2-MG在多发性骨髓瘤的发生发展中起着重要作用,IL-6、β2-MG水平的升高与患者预后密切相关,可将IL-6、β2-MG作为判断多发性骨髓瘤病情评估、治疗效果和预后监测的重要指标。 Objective: To investigate the changes of serum IL-6.β2-MG in patients with multiple myeloma and its clinical significance. Methods: Sixty patients with multiple myeloma were enrolled from June 2008 to Juee 2015 in our hospital. Forty healthy vokmteers were selected as control group.The levels of IL-6 and β2-MG were measured by Radioimmunoassy (RIA). Results: The levels of IL-6 and β2-MG in the MM group were significantly higher than those in the control group (P〈0.05). The levels of IL-6 and β2-MG which were higher than those of ISS I and ISS II (P 〈0.05). Serum IL-6 and β2-MG expression levels in first-treated group and recurrence group of paients with MM were significantly higher than those of control group, and the difference was statistically significant (P〈0.05). Compared with first-treated group, the IL-6 and 132-MG expression level of alleviated group were significantly lower than in the early treated group, and the difference was statistically significant (P〈0.05), the IL-6 and 132-MG expression levels in recurrence group were significantly higher than those of In'st-treated group (P〈0.05). Conclusion: IL-6 and 132-MG play an important role in the development and progression of multiple myeloma, elevation of IL-6 and 132-MG are closely related to the prognosis of patients, IL-6 and 132-MG can be used as an important index to judge the development and prognosis of multiple myeloma.
作者 郑建洵 ZHENG Jian-xun(Department of Clinical Laboratory, the Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou35000)
出处 《实用中西医结合临床》 2016年第11期14-16,共3页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
关键词 多发性骨髓瘤 白介素-6 Β2-微球蛋白 预后 影响因素 Multiple myeloma Interleukin-6 132-microglobulin Prognosis Influencing factors
  • 相关文献

参考文献2

二级参考文献3

共引文献25

同被引文献60

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部